期刊文献+

口服避孕药的应用与宫颈上皮性鳞癌关系的系统评价 被引量:3

Cervical cancer and use of hormonal contraceptives:a systematic review
下载PDF
导出
摘要 目的:探讨口服避孕药的应用与宫颈上皮性鳞癌发病的关系。方法:采用Meta分析的方法,检索PubMed数据库,以及文献追溯等途径,对国外学者自1999年-2008年公开发表的有关口服避孕药的应用与宫颈上皮性鳞癌发病关系的研究文献应用RevMan4.2软件进行综合定量分析。结果:入选的8篇文献包括了3415个病例及4037个对照。以使用口服避孕药与否进行分组,计算使用OC组各研究结果合并的OR值为0.96,95%CI0.85-1.08。结论:使用口服避孕药尚不能认为增加宫颈癌的发病风险。 Objective:To explore the relationship between the use of oral contraceptives and the risk of cervical cancer. Methods:The references on the the relationship between the use of oral contraceptives and cervical cancer collected by database from 1999 to 2008 were adopted with research criteria and analyzed by means of meta - analysis. RevMan4.2 software was applied to process data. Results:Eight eligible studies were identified, including 3415 women with cervical cancer and 4037 controls. Compared with users of oral contraceptives,the relative risks of cervi- cal cancer increased with duration of never use were 0.96 (95% CI 0.85 - 1.08). Concluslon:Using oral contr -aceptives would not increase the risk of cervical cancer.
出处 《现代肿瘤医学》 CAS 2009年第5期917-920,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助(030107)
关键词 口服避孕药 宫颈癌 系统评价 META分析 oral contraceptive cervical cancer systematic review Meta - analysis
  • 相关文献

参考文献10

  • 1Parkin DM, Bry F, Ferlay J, et al. Estimating the world burden [ J]. Golbal Cancer,2001,94 : 153 - 156.
  • 2Shulman LP. Oral contraceptive risk[ J] . Obstet Gynecol Clin N Am,2000,27(4) :695 -704.
  • 3Coker AL, Sanders LC, Bond SM, et al. Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development [ J ]. J Womens Health Gend Based Med,2001,10(5) :441 -449.
  • 4Salazar EL,Sojo -Armada I,Lopez R,et al. The evidence for an etiological relationship between oral contraceptive use and dysplastic change in cervical tissue [ J ]. Gynecol Endocrinol, 2001,15 (1) :23 -28.
  • 5Amy Berrington, Prabhat Jha, Julian Peto, et al. Risk of eervical cancer according to duration of oral contraceptive use [ J ]. Lancet, 2002,360 (8) :410.
  • 6Samuel Shapirol, Lynn Rosenberg, Margaret Hoffman, et al. Risk of invasive cancer of the cervix in relation to the use of injectable rogesogen contraceptives and combined estrogen/progestogen oral contraceptives ( South Africa) [J] . Cancer Causes and Control, 2003,14:485 - 495.
  • 7J Green, A Berrington de Gonzalezl, S Sweetland, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20 -44 years[J]. Br J Cancer,2003,89:2078 - 2086.
  • 8Vanakankovit N, Taneepanichskul S. Effect of oral contraceptives on risk of cervical cancer[ J]. J Med Assoc Thai, 2008,91 (1) :7 -12.
  • 9Doudj hammouda, Nubi Munoz, Rolando Herrero, et al. Cervical carcinoma in Algiers, Algeria human papiUomavirus and lifestyle risk factors[ J ]. Int J Cancer,2005,113:483 - 489.
  • 10Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection : the IARC mulficentric case - control study [ J ]. Lancet,2002,359:1085 - 1092.

同被引文献229

引证文献3

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部